Netherlands
Jordan is an experienced international commercial leader, business-developer, people leader, board member, billion-dollar P&L manager, and dad. He has deep global experience in Healthcare/Pharma, FMCG/CPG, and Tech, has worked in multiple countries/continents, has led broad teams spanning global/regional/local responsibilities, and has continually delivered excellent results throughout his career. He also has experience across all facets of marketing, sales and business development including global brand marketing, high-ROAS performance marketing, leading sales teams of all sizes, strategic business and corporate partnerships, billion-dollar P&L management, and acquisitions & divestments. Jordan is currently Global GM of the Health Division at Kerry, the world’s leading functional ingredient company. In this role, Jordan oversees a team of +400 people and is accountable for the divisional P&L . He oversees all functions across the company’s bio-therapy health products spanning 100 markets and B2B/B2C models. Previously Jordan was Global Commercial Head at Novozymes OneHealth, a world-leading biotech company focused on transforming human health. In this role he led an team of +250 people in general management, sales and marketing across all business verticals on a global scale. Prior to this role, Jordan was Chief Marketing Officer of ResearchGate, the world's largest platform in science with +160 million monthly users +17 million active scientists and HCPs. ResearchGate is funded by Bill Gates and is focused on opening and connecting the world of science to help scientists solve some of the planet's biggest issues. Prior to ResearchGate, Jordan was VP & Global Business Leader at GlaxoSmithKline (GSK) Consumer Healthcare. In this role, Jordan led the $1 billion Voltaren brand (the company's #1 OTC brand); the #2 Pain Relief brand world-wide. During his 4 year tenure, Jordan led an exceptional team that enabled Voltaren to become the world's fastest growing Top 10 OTC brand in the world (4-years in a row) and outpaced the OTC market by over 3x. He managed a multi-functional team of +250 people and a global business in over 150 countries. Before GSK, Jordan was the Head of Marketing for Novartis OTC, Nordics. In this position, he managed a team of 14 marketers across five countries, outpaced market growth by 2.5x, and led the business to become the #1 OTC company in the Nordics for the first time. Prior to this role, Jordan held a series of senior marketing roles at both Novartis Canada and General Mills Canada.
Leading the Global Health & Therapeutics Divisions for Kerry, the world’s largest nutrition and health ingredients company. The divisions include the following verticals: Supplements, Pharma Therapies, Clinical Nutrition, Pet Health, Functional Food, and B2C Probiotics (BioK). The role spans all commercial, R&D, clinical, supply chain and financial responsibilities across 150 countries globally.
Welldium is Europe’s leading dispensary for functional medicine. The platform provides access to & education for the world’s best science-backed functional medicine products for doctors. Doctors look to Welldium as their leading source of knowledge and supply to therapeutics that improve human life.
Medicalmotion is the world’s largest digital therapeutic (DTX) for pain - chronic pain in particular. Chronic pain affects nearly 1B people globally, with incidence on the rise. Many now refer to it as the world’s “silent epidemic”. Medication is the world’s first and only digital therapeutic that is clinically proven to improve chronic pain, sustainably, and safely.
FineMatter (finematter.com) is the world’s leading online platform/marketplace for matching exclusive fine jewelers with consumers who have exquisite taste.
Novozymes is the global market leader in biological solutions serving industries ranging from bio-fuel to human health. The company was spun-off from Novo Nordisk in 2000 (the world’s most valuable pharma company), to focus on leveraging the wonders of biology, not chemistry, to solve countless issues across dozens of industries. Novozymes is a public company listed on the NASDAQ OMX Nordic as NZYM. Jordan was the Global Commercial Head, leading a team of 350 people across 100 countries across GM roles, sales, marketing, supply chain, finance, and commercial innovation. He managed 3 global business models - B2B, B2C and B2HCP and in the process, drove the Human Health division to become one of the fastest growing nutraceutical companies in the industry. He led the company’s first expansion into multiple markets (including China) and managed the acquisition and integration of many companies including MicrobiomeLabs, Precision Biotics, and Synergia.